[1]李 芳.血糖、血脂和实验室相关指标检测在老年2型糖尿病患者病情监控中的应用价值[J].医学信息,2023,36(21):150-153.[doi:10.3969/j.issn.1006-1959.2023.21.035]
　LI Fang.Application Value of Blood Glucose, Blood Lipid and Laboratory Related Indexes in the Monitoring of Elderly Patients with Type 2 Diabetes Mellitus[J].Journal of Medical Information,2023,36(21):150-153.[doi:10.3969/j.issn.1006-1959.2023.21.035]
点击复制

血糖、血脂和实验室相关指标检测在老年2型糖尿病患者病情监控中的应用价值()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
36卷
期数:
2023年21期
页码:
150-153
栏目:
诊疗技术
出版日期:
2023-11-01

文章信息/Info

Title:
Application Value of Blood Glucose, Blood Lipid and Laboratory Related Indexes in the Monitoring of Elderly Patients with Type 2 Diabetes Mellitus
文章编号:
1006-1959（2023）21-0150-04
作者:
李 芳
（德兴市第四人民医院检验科，江西 德兴 334201）
Author(s):
LI Fang
(Laboratory Department of Dexing Fourth People’s Hospital,Dexing 334201,Jiangxi,China)
关键词:
血糖; 血脂; 2型糖尿病
Keywords:
Blood glucose; Blood lipid; Type 2 diabetes mellitus
分类号:
R445
DOI:
10.3969/j.issn.1006-1959.2023.21.035
文献标志码:
A
摘要:
目的 观察血糖、血脂和实验室相关指标检测在老年2型糖尿病患者病情监控中的应用价值。方法 选取2021年6月-2022年10月在我院诊治的52例老年2型糖尿病患者为观察组，并选取同期我院52例体检健康者为对照组，比较两组血糖指标[空腹血糖（FPG）、糖化血红蛋白（HbA1c）]、血脂指标[总胆固醇（TC）、甘油三酯（TG）、低密度脂蛋白胆固醇（LDL-C）、高密度脂蛋白胆固醇（HDL-C）]、实验室指标[超敏 C 反应蛋白（hs-CRP）、血清胱抑素 C（CysC）]水平，比较不同FPG患者血糖、血脂和实验室相关指标水平以及糖尿病微血管病变发生情况，探讨FPG与以上指标的相关性。结果 观察组FPG、HbA1c高于对照组（P＜0.05）；观察组TC、TG、LDL-C高于对照组，HDL-C低于对照组（P＜0.05）；观察组hs-CRP、CysC高于对照组（P＜0.05）；FPG≤7.2 mmol/L 的患者FPG、HbA1c、TC、TG、LDL-C、hs-CRP、CysC均低于FPG＞7.2 mmol/L的患者，HDL-C高于FPG＞7.2 mmol/L的患者（P＜0.05）；FPG≤7.2 mmol/L的患者糖尿病微血管病变发生率低于FPG＞7.2 mmol/L的患者（P＜0.05）；FPG与HbA1c、TC、TG、LDL-C、hs-CRP、CysC呈正相关，与HDL-C呈负相关（P＜0.05）。结论 血糖、血脂和实验室相关指标与老年2型糖尿病患者病情具有密切的关系，可一定程度反映病情进展，为临床评估病情提供可靠参考。
Abstract:
Objective To observe the application value of blood glucose, blood lipid and laboratory related indexes in the monitoring of elderly patients with type 2 diabetes mellitus.Methods A total of 52 elderly patients with type 2 diabetes who were diagnosed and treated in our hospital from June 2021 to October 2022 were selected as the observation group, and 52 healthy people who underwent physical examination in our hospital during the same period were selected as the control group. The blood glucose indexes [fasting blood glucose (FPG), glycosylated hemoglobin (HbA1c)], blood lipid indexes [total cholesterol (TC), triglyceride (TG), low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C)], laboratory indexes [high sensitivity C-reactive protein (hs-CRP), serum cystatin C (CysC)] levels were compared between the two groups. In addition, the levels of blood glucose, blood lipid and laboratory related indexes and the occurrence of diabetic microangiopathy in patients with different FPG were compared, and the correlation between FPG and the above indexes was discussed.Results FPG and HbA1 c in the observation group were higher than those in the control group (P<0.05). TC, TG and LDL-C in the observation group were higher than those in the control group, and HDL-C was lower than that in the control group (P<0.05). FPG, HbA1 c, TC, TG, LDL-C, hs-CRP and CysC in patients with FPG≤7.2 mmol/L were lower than those in patients with FPG>7.2 mmol/L, and HDL-C was higher than that in patients with FPG>7.2 mmol/L (P<0.05). The incidence of diabetic microangiopathy in patients with FPG≤7.2 mmol/L was lower than that in patients with FPG>7.2 mmol/L (P<0.05). FPG was positively correlated with HbA1 c, TC, TG, LDL-C, hs-CRP and CysC, and negatively correlated with HDL-C (P<0.05).Conclusion Blood glucose, blood lipid and laboratory related indeses are closely related to the condition of elderly patients with type 2 diabetes mellitus, which can reflect the progress of the disease to a certain extent, and provide a reliable reference for clinical evaluation of the disease.

参考文献/References:

[1]马越,杜菲菲,王晶,等.珍芪降糖胶囊联合二甲双胍治疗2型糖尿病的临床疗效研究[J].现代生物医学进展,2020,20(8):1592-1595.[2]Sun LL,Liu TJ,Li L,et al.Transplantation of betatrophin-expressing adipose-derived mesenchymal stem cells induces β-cell proliferation in diabetic mice[J].Int J Mol Med,2017,39(4):936-948.[3]中华医学会糖尿病学分会.中国2型糖尿病防治指南（2017年版）[J].中华糖尿病杂志,2018,10(1):64-67.[4]卜艳龙,刘媛媛,卞文.2 型糖尿病下肢血管病变的血清脂肪因子血管生成素样蛋白4水平及其临床意义研究[J].临床和实验医学杂志,2019,18(23):2540-2543.[5]Liu D,Qu H,Wang H,et al.Relationship between serum betatrophin levels and the first-phase of glucose-stimulated insulin secretion [J].Obes Res Clin Pract,2018,12(Suppl 2):9-15.[6]莫娟,欧阳俊,王颖,等.2型糖尿病患者血清 Betatrophin 与周围神经病变的关系[J].中国现代医学杂志,2020,30(4):106-109.[7]Aibara D,Matsuo K,Yamano S,et al.Insulin induces expression of the hepatic vaspin gene[J].Endocr J,2020,67(1):9-14.[8]黄永健,张民乐.尿酸干预对老年高血压合并糖尿病患者心功能的影响[J].泰山医学院学报,2017,38(5):519-520.[9]邢丹.糖化血红蛋白和血脂检测用于2型糖尿病检测中的临床价值[J].河南预防医学杂志,2019,30(11):829-830,866.[10]石舒原,赵厚宇,刘志科,等.多状态马尔科夫模型估计2型糖尿病患者慢性并发症累积数量的转移概率及影响因素研究[J].中华流行病学杂志,2021,42(7):1274-1279.[11]张迎,杜月芳,倪燕燕,等.住院早发2型糖尿病患者代谢特征及慢性并发症危险因素分析[J].山西医药杂志,2021,50(2):220-222.[12]李亚飞.不同阶段2型糖尿病肾病(DN)患者合并糖尿病慢性并发症的发生率分析[J].实用糖尿病杂志,2020,16(6):80.[13]杨佳,胡毅.2型糖尿病患者慢性并发症相关危险因素分析[J].检验医学与临床,2020,17(18):2655-2657.[14]李伟露,李影.老年T2DM患者血清CRP、尿微量白蛋白的水平及其与慢性血管并发症的关系[J].海南医学,2019,30(6):699-702.[15]顾淑君,张秋伊,周正元,等.糖化血红蛋白变异指数与2型糖尿病患者糖尿病慢性并发症的相关性研究[J].华南预防医学,2021,47(4):431-435.[16]王雅萍,路丽,张秀华,等.2型糖尿病患者糖化血红蛋白与空腹血糖的相关性分析[C]//中华医学会,中华医学会内分泌学分会.中华医学会第十次全国内分泌学学术会议论文汇编.2011:500-501.[17]李方.2 型糖尿病患者糖化血红蛋白水平与血脂的相关性[J].深圳中西医结合杂志,2018,28(16):121-123.[18]张辉荣.老年2型糖尿病患者糖化血红蛋白与血脂的关系及采用辛伐他丁联合非诺贝特治疗的意义[J].泰山医学院学报,2018,39(10):1158-1159.[19]孙爱童,刘炯鸥.2 型糖尿病患者下肢动脉血管回声跟踪技术检测指标与血脂及血糖的相关性[J].中华实用诊断与治疗杂志,2017,31(1):62-64.

相似文献/References:

[1]刘 静.冠状动脉粥样硬化性心脏病合并糖尿病的血脂检验结果分析[J].医学信息,2018,31(04):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
　LIU Jing.Analysis of Blood Lipid Test Results in Coronary Atherosclerotic Heart Disease Complicated with Diabetes Mellitus[J].Journal of Medical Information,2018,31(21):154.[doi:10.3969/j.issn.1006-1959.2018.04.057]
[2]张宇宁.黄酮类化合物治疗糖尿病及其并发症的研究[J].医学信息,2018,31(05):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
　ZHANG Yu-ning.Study on Flavonoids in the Treatment of Diabetes Mellitus and its Complications[J].Journal of Medical Information,2018,31(21):50.[doi:10.3969/j.issn.1006-1959.2018.05.018]
[3]刘立宁.便携式血糖仪与生化分析仪实际方法检测血糖结果比对分析[J].医学信息,2018,31(07):155.[doi:10.3969/j.issn.1006-1959.2018.07.054]
　LIU Li-ning.Comparison and Analysis of the Results of Blood Glucose Detection by Portable Blood Glucose Analyzer and Biochemical Analyzer[J].Journal of Medical Information,2018,31(21):155.[doi:10.3969/j.issn.1006-1959.2018.07.054]
[4]刘爱君.糖化血红蛋白测定在糖尿病诊断中的应用价值分析[J].医学信息,2018,31(08):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
　LIU Ai-jun.Analysis of the Value of Determination of Glycosylated Hemoglobin in the Diagnosis of Diabetes Mellitus[J].Journal of Medical Information,2018,31(21):161.[doi:10.3969/j.issn.1006-1959.2018.08.057]
[5]王 荣.诺和锐特充治疗妊娠期糖尿病的临床效果观察[J].医学信息,2018,31(08):186.[doi:10.3969/j.issn.1006-1959.2018.08.069]
　WANG Rong.Clinical Observation on the Treatment of Gestational Diabetes Mellitus with Novoterol[J].Journal of Medical Information,2018,31(21):186.[doi:10.3969/j.issn.1006-1959.2018.08.069]
[6]刘 洁.糖尿病药物治疗的现状及研究进展[J].医学信息,2022,35(09):69.[doi:10.3969/j.issn.1006-1959.2022.09.017]
　LIU Jie.Current Situation and Research Progress of Diabetic Drug Therapy[J].Journal of Medical Information,2022,35(21):69.[doi:10.3969/j.issn.1006-1959.2022.09.017]
[7]朱 玉,戴 夫,彭 琼.胃肠息肉患者血脂水平影响因素及相关性分析[J].医学信息,2019,32(02):79.[doi:10.3969/j.issn.1006-1959.2019.02.023]
　ZHU Yu,DAI Fu,PENG Qiong.Influential Factors and Correlation Analysis of Blood Lipid Levels in Patients with Gastrointestinal Polyps[J].Journal of Medical Information,2019,32(21):79.[doi:10.3969/j.issn.1006-1959.2019.02.023]
[8]吴彦卿.妊娠期同型半胱氨酸和血脂水平对重度子痫前期的预测价值[J].医学信息,2018,31(16):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
　WU Yan-qing.Predictive Value of Homocysteine and Blood Lipid Levels during Pregnancy in Severe Preeclampsia[J].Journal of Medical Information,2018,31(21):157.[doi:10.3969/j.issn.1006-1959.2018.16.050]
[9]张 明,李 超,谷海飞.不同晶体液对胃肠道手术婴儿电解质、血糖的影响[J].医学信息,2019,32(01):69.[doi:10.3969/j.issn.1006-1959.2019.01.023]
　ZHANG Ming,LI Chao,GU Hai-fei.Effects of Different Crystalloids on Electrolytes and Blood Glucose in Infants Undergoing Gastrointestinal Surgery[J].Journal of Medical Information,2019,32(21):69.[doi:10.3969/j.issn.1006-1959.2019.01.023]
[10]胡坤其,冯增斌,邓玉娇.非糖尿病患者在非体外循环下行CABG术围手术期血糖和血乳酸水平变化分析[J].医学信息,2019,32(01):103.[doi:10.3969/j.issn.1006-1959.2019.01.031]
　HU Kun-qi,FENG Zeng-bin,DENG Yu-jiao.Analysis of Perioperative Blood Glucose and Blood Lactate Levels in Non-diabetic Patients Undergoing CABG without Cardiopulmonary Bypass[J].Journal of Medical Information,2019,32(21):103.[doi:10.3969/j.issn.1006-1959.2019.01.031]
[11]牟 婷,张朝阳.胰岛素联合唑来膦酸治疗糖尿病骨质疏松症对患者血清指标的影响[J].医学信息,2019,32(22):135.[doi:10.3969/j.issn.1006-1959.2019.22.045]
　MU Ting,ZHANG Chao-yang.Effect of Insulin Combined with Zoledronic Acid on Serum Markers in Patients with Diabetic Osteoporosis[J].Journal of Medical Information,2019,32(21):135.[doi:10.3969/j.issn.1006-1959.2019.22.045]
[12]张 彤.利拉鲁肽联合胰岛素治疗新诊断肥胖2型糖尿病的临床疗效及安全性[J].医学信息,2022,35(05):159.[doi:10.3969/j.issn.1006-1959.2022.05.042]
　ZHANG Tong.Clinical Efficacy and Safety of Liraglutide Combined with Insulin in the Treatment of Newly Diagnosed Obese Type 2 Diabetes Mellitus[J].Journal of Medical Information,2022,35(21):159.[doi:10.3969/j.issn.1006-1959.2022.05.042]

更新日期/Last Update: 1900-01-01